-
A new political era for Colombia: a hard-right president promises order, growth and confrontation.
-
President Trump says he has signed two new orders targeting birthright citizenship. And, Iran is aiming to ban U.S. ships from the Strait of Hormuz.
-
A new study is out that looked at various ways to try to tackle poverty in Ethiopia. Turns out, cash helps, but the impact of therapy is less clear.
-
At a time of increased conflict between elephants and humans, as elephant habitats are converted to intensive agriculture, the Hurulu Eco Park is a place where the animals can graze unimpeded.
-
The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit the mark — until this year.
-
FIFA said Wednesday it had apologized for errors made over Gianni Infantino's failed plan to sell stakes in the World Cup and that senior staff in attendance at a crisis meeting in Morocco "reaffirmed their full support" for his presidency.
-
Regional police and prosecutors said an airport employee discovered a drone near the airport's south runway with "an unknown explosive device," and the object was examined by police
-
Hasina's speech marked the second anniversary of her ouster. She fled Bangladesh by helicopter following nearly two months of protests in 2024 that left nearly 1,400 people dead, according to the United Nations.
-
Another overnight attack killed at least 17 people in and around Kyiv. The strikes come as Ukraine faces a growing shortage of the interceptor missiles used to defend the capital.
-
Candidates backed by twice-elected former Prime Minister Nawaz Sharif's Pakistan Muslim League-N party have won 24 of the 34 seats decided in the first two phases of voting, the election commission, said Wednesday.
-
A 73-year-old retired nurse's decision to learn to write Tibetan language offers a glimpse into how some embrace their language and cultural identity in Tibet.
-
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.